IndiaRF begins $250-300M stake sale in Synthimed Labs
India Resurgence Fund has launched a process to sell a minority stake in API maker Synthimed Labs, targeting a $1 billion valuation. Read the full details on the deal and the company's growth.
Category : Search result: CRAMS
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Page 1 of 1